Takeda Pharmaceutical Agrees to $2.4 Billion Actos Settlement

Late last month, Takeda Pharmaceutical Company – one of the largest pharmaceutical companies in the world – agreed to a $2.4 billion settlement to resolve thousands of lawsuits involving Actos. A popular prescription medication used to treat Type 2 diabetes, Actos has been associated with adverse side effects, including many cases of bladder cancer.

The settlement – reached Tuesday, April 28 th in Illinois Circuit Court of Cook County – will help provide compensation to thousands of victims who claim they were diagnosed with bladder cancer after taking Actos. As part of the settlement terms, Takeda has not admitted wrongdoing.

Takeda came under scrutiny after consumers began reporting bladder cancer diagnoses connected to Actos at alarming rates. After investigating claims, the U.S. Food and Drug Administration (FDA) released a statement that people who took Actos for more than one year faced a 40% increase in bladder cancer risks.

The substantial settlement speaks to the rights of consumers who are harmed by unsafe products and medications. If you have questions about your rights following an illness or injury you believe was caused by a pharmaceutical product, contact Nemeroff Law Firm for a free consultation.

Learn More About


  • What is Mesothelioma?

    Learn the facts.

  • Mesothelioma Symptoms

    Learn the facts.

  • Mesothelioma Diagnosis

    Learn the facts.

  • Asbestos

    Learn the facts.